Jumat, 06 April 2018

OmiX Shivom token sales

Sales Contribution Shivom Token Can Take Benefits From Hedging In The World's First Hedge Token


shivom ico


OmiX Shivom token sales is the first time supporters who can protect the risk of their contribution as a result of partnership with DeHedge's decentralized risk hedging platform
Shivom, the blockchain genomics platform that aims to build a world-leading genomic data center to support personal healthcare, has signed an agreement with a decentralized risk protection platform, DeHedge that will allow contributors in token sales to protect risks associated with their contribution in Token OmiX .
In the first partnership of its kind, which will produce the world's first event for token sale and cryptocurrency markets, DeHedge has cut Shivom's OmiX (OMX) token for a total of $ 3 million. The risk hedging platform, which helps protect contributors against any unforeseen changes, can guarantee 50% risk coverage when hedging events occur.
"As we prepare for the sale of our main token, we want to place any and all mechanisms that encourage potential contributors to engage in projects that will transform the precision drug market. Our partnership with DeHedge is a great example of this approach, which we believe will help build momentum in the project and convince supporters that the entire team has the best interests in mind for the long term, "said Dr. Axel Schumacher, Co. -Founder and CEO of Shivom.
DeHedge aims to reduce the risk of contributing token sales to zero. A rigorous selection process for projects involves a panel of three in-house experts who choose potential projects based on the 'Manifesto of the Respectable Startup'. This was then submitted to DeHedge's founder, who accepted or rejected him. Shivom is the first project to successfully pass the selection process.
"We have traveled a long way, both in terms of improving our assessment model and in terms of adapting the hedging algorithm to the crypto market. Currently, there are more than 25 projects in the funnel for selected placements that have passed the automatic assessment, and preliminary agreements have been reached with four of them. However, Shivom is the first to sign an agreement on the placement of a hedged token of $ 3 million, "said Dmitry Ansimov, Co-Founder and COO DeHedge.
The main sales of OmiX Shivom tokens will take place in the coming weeks, with interested parties encouraged to join the whitelist as soon as possible to avoid disappointment.
About Shivom:
Shivom is driving the next genomic era through blockchain technology - protecting identity, personalizing health care and life-changing. For the first time, precision treatment ecosystems will offer open web markets for other providers to add not only genomic information but also analytics and related applications and services to encourage personalized medicine. Shivom intends to expand its services to form a global network of laboratories and related research centers, as well as genetic counselors and other related services. 
For more information, please visit:  https  : //  shivom  io  /
About DeHedge:
DEHEDGE GROUP LTD. registered in the UK, is a group of international fintech companies that provide hedging solutions for contributors into currencies and tokens, as well as other financial services for cryptocurrency and token markets. DeHedge as a decentralized risk hedge platform guarantees that the token sales contributor will be compensated in case of exchange rate fluctuations, fraud, and cancellation of the project.

Tidak ada komentar:

Posting Komentar